Search for Clinical Trial Results

Carcinoma, Ductal - 30 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast Condition: Carcinoma, Ductal, Breast Date: 2007-05-03 Interventions:
|
Recruiting |
Study Name: Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (BEVABEL) Condition: Collecting Duct Carcinoma (Kidney) Date: 2015-02-09 Interventions: Drug: Bevacizumab Patients will be treated for a maximum o |
Completed |
Study Name: Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer Condition: Carcinoma, Ductal, Breast Date: 2013-05-14 Interventions:
|
Terminated |
Study Name: Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer Condition: Ductal Carcinoma Date: 2007-04-17 Interventions:
|
Active, not recruiting |
Study Name: Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer Condition:
Date: 2005-09-12 Interventions:
|
Active, not recruiting |
Study Name: The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer Condition: Mammary Ductal Carcinoma Date: 2011-11-30 |
Active, not recruiting |
Study Name: A Feasibility Study for Women Receiving Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma Condition: Breast Cancer Date: 2014-05-12 Interventions: Other: Feasibility study All participants will have blood draws for biomarkers during the course of the |
Completed |
Study Name: Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer Condition:
Date: 2011-12-15 Interventions: Procedure: axillary dissection Conservative breast surgery with or without axillary dissection |
Completed |
Study Name: Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer Condition: Infiltrating Ductal Carcinoma Date: 2012-06-14 |
Active, not recruiting |
Study Name: Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma Condition: Renal Cell Carcinoma Date: 2012-12-22 Interventions:
|